Yosprala
Product Images NDC 73568-005

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Yosprala (NDC 73568-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaceutika Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (Label 004)

This text appears to be a description for a medication that comes in tablet form. The recommended dose is to take one tablet daily at least 60 minutes before a meal. The tablet contains 81mg of aspirin and 40mg of omeprazole. It is important to swallow the tablet whole with liquid and to not split, chew, crush, or dissolve it. The medication should be stored at 25°C and kept out of the reach of children. The accompanying medication guide should be dispensed with the tablets.*

FDA Label Image

Image-2 (Label 005)

Yosprala is a medication that combines delayed-release aspirin (325mg) and immediate-release omeprazole (40mg) in a single tablet. It is taken once daily at least 60 minutes before a meal. The tablet should be swallowed whole with liquid and stored at room temperature. It is essential to keep out of reach of children, and the medication guide should accompany the prescription. The tablet should not be chewed, crushed, or dissolved.*

FDA Label Image

Chemical Structure (Yosprala 01)

FDA Label Image

Chemical Structure (Yosprala 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.